https://www.avient.com/products/long-fiber-technology/complet-maximum-toughness
Explore What’s Possible
Explore What’s Possible
Explore What's Possible
https://www.avient.com/investor-center/news/polyone-declares-quarterly-dividend-increase-30-announces-three-year-dividend-increase-plan
We are very excited about our growth opportunities and remain fully committed to investing in our businesses through innovation, commercial and technical resources and M&A, as we execute our four-pillar strategy to serve our customers."
About
In this press release, statements that are not reported financial results or other historical information are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.
https://www.avient.com/investor-center/news/future-mobility-innovations-gain-traction-visionary-polyone-materials-and-services-portfolio
plans to present additional details about transportation solutions as one of several high-growth focus areas that underpin the company's expectation of delivering double digit EPS growth in 2018 and beyond.
About
In this press release, statements that are not reported financial results or other historical information are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.
https://www.avient.com/investor-center/news/avient-signs-agreement-divest-distribution-business-hig-capital-950-million
We are excited about our future as a pure play specialty formulator of sustainable solutions."
About
In this press release, statements that are not reported financial results or other historical information are "forward looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.
https://www.avient.com/news/polyone-expands-healthcare-portfolio-biomerics’-specialty-medical-solutions
About PolyOne
About Biomerics
In this press release, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
https://www.avient.com/sites/default/files/2021-05/2021-colormatrix-quick-guide-to-liquid-color_0.pdf
What level of technical support do you receive from your colorant supplier?
Such
testing often goes beyond what is required by the
legislation.
Avient makes no representations, guarantees, or warranties of any kind with respect to the information contained in this document about its accuracy, suitability
for particular applications, or the results obtained or obtainable using the information.
https://www.avient.com/sites/default/files/2021-05/2021-colormatrix-quick-guide-to-liquid-color.pdf
What level of technical support do you receive from your colorant supplier?
Such
testing often goes beyond what is required by the
legislation.
Avient makes no representations, guarantees, or warranties of any kind with respect to the information contained in this document about its accuracy, suitability
for particular applications, or the results obtained or obtainable using the information.
https://www.avient.com/knowledge-base/article/securing-supplies-medical-plastic-solutions
For the plastics used in these medical applications, this can mean compliance with the relevant chapters of the International Organization for Standardization (ISO), the United States Pharmacopeia Class VI (USP VI) the European Pharmacopeia (EP 3.1), and the International Conference on Harmonization (ICH Q3D) standards and guidelines.
For healthcare companies, it means the selected custom colorant or functional additive can be procured from the Mevopur site most conveniently located for the converter, reducing the risk of supply disruption that can be caused by cross-border trade restrictions.
Having multiple sites also means there is always a backup site producing to the same high-quality standards.
https://www.avient.com/knowledge-base/article/securing-supplies-medical-plastic-solutions?rtype[]=1164
For the plastics used in these medical applications, this can mean compliance with the relevant chapters of the International Organization for Standardization (ISO), the United States Pharmacopeia Class VI (USP VI) the European Pharmacopeia (EP 3.1), and the International Conference on Harmonization (ICH Q3D) standards and guidelines.
For healthcare companies, it means the selected custom colorant or functional additive can be procured from the Mevopur site most conveniently located for the converter, reducing the risk of supply disruption that can be caused by cross-border trade restrictions.
Having multiple sites also means there is always a backup site producing to the same high-quality standards.
https://www.avient.com/knowledge-base/article/securing-supplies-medical-plastic-solutions?pname[]=17814
For the plastics used in these medical applications, this can mean compliance with the relevant chapters of the International Organization for Standardization (ISO), the United States Pharmacopeia Class VI (USP VI) the European Pharmacopeia (EP 3.1), and the International Conference on Harmonization (ICH Q3D) standards and guidelines.
For healthcare companies, it means the selected custom colorant or functional additive can be procured from the Mevopur site most conveniently located for the converter, reducing the risk of supply disruption that can be caused by cross-border trade restrictions.
Having multiple sites also means there is always a backup site producing to the same high-quality standards.